# Lanreotide Acetate

NDC: 69097-890
Generic name: lanreotide acetate
Labeler / Manufacturer: Cipla USA Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION
Routes: SUBCUTANEOUS
Marketing started: 20211224

FDA application: NDA215395

## Active ingredients

- LANREOTIDE ACETATE: 90 mg/.3mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"69097-890"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=69097-890
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=11da176a-99bc-4ada-8b3f-6bd2b37a6313